全文获取类型
收费全文 | 3977篇 |
免费 | 218篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 78篇 |
妇产科学 | 87篇 |
基础医学 | 652篇 |
口腔科学 | 32篇 |
临床医学 | 389篇 |
内科学 | 842篇 |
皮肤病学 | 60篇 |
神经病学 | 407篇 |
特种医学 | 158篇 |
外科学 | 572篇 |
综合类 | 5篇 |
一般理论 | 6篇 |
预防医学 | 189篇 |
眼科学 | 74篇 |
药学 | 276篇 |
中国医学 | 12篇 |
肿瘤学 | 341篇 |
出版年
2023年 | 23篇 |
2022年 | 16篇 |
2021年 | 100篇 |
2020年 | 49篇 |
2019年 | 87篇 |
2018年 | 101篇 |
2017年 | 86篇 |
2016年 | 81篇 |
2015年 | 107篇 |
2014年 | 137篇 |
2013年 | 200篇 |
2012年 | 257篇 |
2011年 | 278篇 |
2010年 | 161篇 |
2009年 | 126篇 |
2008年 | 247篇 |
2007年 | 233篇 |
2006年 | 203篇 |
2005年 | 227篇 |
2004年 | 194篇 |
2003年 | 179篇 |
2002年 | 165篇 |
2001年 | 42篇 |
2000年 | 38篇 |
1999年 | 31篇 |
1998年 | 36篇 |
1997年 | 18篇 |
1996年 | 24篇 |
1993年 | 16篇 |
1992年 | 22篇 |
1991年 | 29篇 |
1990年 | 22篇 |
1989年 | 26篇 |
1988年 | 30篇 |
1987年 | 21篇 |
1986年 | 24篇 |
1985年 | 22篇 |
1984年 | 29篇 |
1983年 | 20篇 |
1982年 | 21篇 |
1981年 | 22篇 |
1979年 | 21篇 |
1978年 | 27篇 |
1977年 | 26篇 |
1976年 | 22篇 |
1974年 | 17篇 |
1973年 | 16篇 |
1971年 | 18篇 |
1969年 | 16篇 |
1966年 | 16篇 |
排序方式: 共有4210条查询结果,搜索用时 622 毫秒
1.
Fabrice Kwiatkowski Isabelle Perthus Nancy Uhrhammer Christine Francannet Marie Arbre Yannick Bidet Yves-Jean Bignon 《Congenital anomalies》2020,60(1):22-31
In a previous article we reported that mutations favoring cancer at adulthood seemed to improve fertility and limit miscarriages. Because spontaneous abortion may result from anomalies in embryo, we questioned if an increased frequency of congenital malformation could be evidenced among cancer-prone families. Oncogenetics database (≈193 000 members) of the comprehensive cancer center Jean Perrin was crossed with regional registry of congenital malformations (≈10 000). Among children born between 1986 and 2011, 176 children with malformation matched in both databases. In breast/ovaries cancer-prone families, the risk for malformations was multiplied by 2.4 [1.2-4.5] in case of a BRCA1 mutation. Frequencies of malformation in BRCA2 and MMR mutated families were similar to families without a cancer syndrome. In comparison to malformations concerning a unique anatomical system, multimalformations were significantly more frequent in case of BRCA or MMR mutations: compared to families without cancer syndrome, the risk of multimalformations was multiplied by 4.1 [0.8-21.7] for cancer-prone families but with no known deleterious mutation, by 6.9 [1.2-38.6] in families with a known mutation but an unknown parental mutational status and by 10.4 [2.3-46.0] when one parent carried the familial mutation. No association with the type of anatomical system was found, nor with multiple births. These results suggest that BRCA and MMR genes play an important role in human embryogenesis and that if their function is lowered because of heterozygote mutations, congenital malformations are either more likely (BRCA1 mutations) and/or more susceptible to concern several anatomical systems. 相似文献
2.
Fabrice Barlesi Edward B. Garon Dong-Wan Kim Enriqueta Felip Ji-Youn Han Joo-Hang Kim Myung-Ju Ahn Mary Jo Fidler Matthew A. Gubens Gilberto de Castro Veerle Surmont Qiao Li Anne C. Deitz Gregory M. Lubiniecki Roy S. Herbst 《Journal of thoracic oncology》2019,14(5):793-801
Introduction
In the phase II/III KEYNOTE-010 study (ClinicalTrials.gov, NCT01905657), pembrolizumab significantly prolonged overall survival over docetaxel in patients with previously treated, programmed death ligand 1–expressing (tumor proportion score ≥ 1%), advanced NSCLC. Health-related quality of life (HRQoL) results are reported here.Methods
Patients were randomized 1:1:1 to pembrolizumab 2 or 10 mg/kg every 3 weeks or docetaxel 75 mg/m2 every 3 weeks. HRQoL was assessed using European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLC) Core 30 (C30), EORTC QLQ–Lung Cancer 13 (LC13), and EuroQoL-5D. Key analyses included mean baseline-to-week-12 change in global health status (GHS)/quality of life (QoL) score, functioning and symptom domains, and time to deterioration in a QLQ-LC13 composite endpoint of cough, dyspnea, and chest pain.Results
Patient reported outcomes compliance was high across all three instruments. Pembrolizumab was associated with better QLQ-C30 GHS/QoL scores from baseline to 12 weeks than docetaxel, regardless of pembrolizumab dose or tumor proportion score status (not significant). Compared with docetaxel, fewer pembrolizumab-treated patients had “deteriorated” status and more had “improved” status in GHS/QoL. Nominally significant improvement was reported in many EORTC symptom domains with pembrolizumab, and nominally significant worsening was reported with docetaxel. Significant prolongation in true time to deterioration for the QLQ-LC13 composite endpoint emerged for pembrolizumab 10 mg/kg compared to docetaxel (nominal two-sided p = 0.03), but not for the 2-mg/kg dose.Conclusions
These findings suggest that HRQoL and symptoms are maintained or improved to a greater degree with pembrolizumab than with docetaxel in this NSCLC patient population. 相似文献3.
4.
5.
H.-A. Adams Chr. Altheim S. Knopf B. Krause-Dietering Prof. Dr. U. Kreimeier L. Latasch H. Lemke Th. Luiz J. Pfefferkorn J. Schmidt W.-H. Storch D. Stratmann U. Tittelbach St. Wenderoth 《Notfall & Rettungsmedizin》2007,10(1):13-22
Ohne Zusammenfassung 相似文献
6.
Thierry A Folliguet Fabrice Vanhuyse Zanis Konstantinos Fran?ois Laborde 《European journal of cardio-thoracic surgery》2005,28(1):172-173
We report our initial experience with aortic valve replacement using robotic assistance. All procedures were performed with peripheral cardiopulmonary bypass, transthoracic aortic cross-clamp, and antegrade cold crystalloid cardioplegia. One or two ports and a 5-cm intercostal incision in the right chest were used for access. All patients had aortic valve replacement performed robotically. Between February and September 2004, five patients underwent robotic aortic valve replacement. The mean age was 59 years (range 35-82 years). There were no incisional conversions, death, stokes, or reoperations for bleeding. Overall mean study times were as follows: procedure, 231.2 min (range 180-315 min); cardiopulmonary bypass, 121.5 min (range 83-173 min), and cross-clamp, 98.2 min (range 67-140 min). One patient developed postoperative pneumonia. Aortic valve replacement can be successfully performed with the da Vinci robotic system. 相似文献
7.
N. Uzunov M. Kutchoukov Chr Kolchev 《The Italian Journal of Neurological Sciences》1991,12(2):175-179
45 patients with spinocerebellar degeneration (SCD) underwent through quantitative investigation of the ventricular and cisternal
systems by CT scanning and threshold vibrometry in the limbs to find out whether these parameters could be used for distinguishing
mainly spinal from cerebellar forms or from olivopontoce-rebellar atrophy. The increase in the vibration sense threshold and
the mild atrophy in the posterior cranial fossa proved typical of spinal forms and the reverse for cerebellar forms. In olivopontocerebellar
atrophy enlargement of the cisterns and dilatation of the ventricles always exceeded 85% of normal values.
Sommario 45 pazienti affetti da degenerazione spinocerebellare (SCD) sono stati sottoposti ad uno studio approfondito di esplorazione quantitativa del sistema ventricolare e cisternale alla TAC e della soglia di percezione vibratoria agli arti per valutare la possibilità di distinguere con questi parametri le forme prevalentemente spinali da quelle cerebellari o delle atrofie olivopontocerebellari. L'aumento della soglia vibratoria e la modesta atrofia in fossa posteriore è risultata tipica delle forme spinali, mentre l'inverso si verifica per le forme cerebellari. Nelle atrofie olivopontocerebellari l'allargamento delle cisterne e la dilatazione dei ventricoli supera quasi sempre l'85% rispetto ai casi normali.相似文献
8.
H. Chr Geelmuyden 《Virchows Archiv : an international journal of pathology》1886,105(1):136-169
Ohne ZusammenfassungHierzu Taf. VIII. 相似文献
9.
Christophe Doddoli Adrian Aragon Fabrice Barlesi Bruno Chetaille Stéphane Robitail Roger Giudicelli Pierre Fuentes Pascal Thomas 《European journal of cardio-thoracic surgery》2005,27(4):680-685
OBJECTIVE: To assess the therapeutic effect of the extent of lymph node dissection performed in patients with a stage pI non-small-cell lung cancer (NSCLC). METHODS: We analysed data on 465 patients with stage I NSCLC who were treated with surgical resection and some form of lymph node sampling. The median number of lymph node sampled was 10 and the median number of ipsilateral mediastinal lymph node stations sampled was two. We chose to define a procedure that harvested 10 or more lymph nodes and sampled two or more ipsilateral mediastinal stations as a lymphadenectomy, by contrast with sampling when one or both criteria were not satisfied. The effect of the surgical techniques: lymph node sampling (LS; n=207) vs. lymphadenectomy (LA; n=258) on 30-day mortality and overall survival were investigated. RESULTS: A total of 6244 lymph nodes was examined, including 4306 mediastinal lymph nodes. The mean (+/-SD) numbers of removed lymph nodes were 7+/-6.1 per patient following LS vs.18.6+/-9.3 following LA (P=0.001). An average mean of 1+/-0.90 mediastinal lymph node station per patient was sampled following LS vs. 2.7+/-0.8 following LA (P<10(-6)). Overall 30-day mortality rates were 2.4 and 3.1%, respectively. LA was disclosed as a favourable prognosticator at multivariate analysis (Hazard Risk: 1.43; 95% Confidence Interval: 1.00-2.04; P=0.048), together with younger patient age, absence of blood vessels invasion, and smaller tumour size. CONCLUSIONS: Importance of lymph node dissection affects patients outcome, while it does not enhance the operative mortality. A minimum of 10 lymph nodes assessed, and two mediastinal stations sampled are suggested as possible pragmatic markers of the quality of lymphadenectomy. 相似文献
10.